WASHINGTON (AP) – A once-a-month injection to treat alcoholism won federal approval Thursday, expanding availability of a drug previously sold only in daily pill form.

The Food and Drug Administration approved Vivitrol, spokeswoman Laura Alvey said. Cambridge, Mass.-based Alkermes Inc. will make the injectable form of the drug, also known as naltrexone. Cephalon Inc., of Frazer, Pa., will market and sell it.

The companies hope monthly injections of the drug, to be administered at a doctor’s office, will prove an easier regimen for alcoholics to follow than the daily pill. The drug is to be used in conjunction with counseling or group therapy, the companies said.

The drug works by blocking neurotransmitters in the brain believed to be associated with alcohol dependence, diminishing the craving for alcohol.

“This is the first and only long-acting medication available for patients, and so I’m thrilled that it is going to become an important treatment option for patients and their doctors,” said Richard Pops, Alkermes’ chief executive officer.

Pops said the drug’s price wouldn’t be decided until its U.S. launch in late June. He didn’t offer sales predictions and said initial marketing would not include direct-to-consumer advertising.

Naltrexone initially won FDA approval for treating alcoholism in 1994. It first was sold to treat narcotic dependency. Other drugs to treat alcoholism include Antabuse, which has been sold since 1948.

The market for Antabuse and naltrexone has been limited, with annual sales in the low tens of millions of dollars.

Vivitrol will carry the strongest warning prescription drugs can bear. The black-box warning will caution patients that the drug can cause liver damage, said Dr. Elliot Ehrich, Alkermes’ vice president. The pill form of the drug bears a similar warning, which says liver damage was observed at higher-than-recommended doses.


Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.